Who is sponsoring NCT04375748?

NCT04375748 is sponsored by University Hospital, Toulouse.

What condition does NCT04375748 study?

NCT04375748 studies Acute Myocarditis.

Is NCT04375748 still recruiting?

NCT04375748 is currently completed. Last updated 24 July 2023.

Last reviewed 2023-07-24 · How we verify

NCT04375748: MYOCOVID

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases

Completed Last updated 24 July 2023

What this trial tests

trial testing Performing routine care (clinical and paraclinical tests) in Acute Myocarditis in 756 participants. Completed in 28 December 2021.

Timeline

15 April 2020

Primary endpoint
28 December 2021

28 December 2021

Quick facts

Lead sponsor	University Hospital, Toulouse
Status	Completed
Study type	OBSERVATIONAL
Enrollment	756
Start date	15 April 2020
Primary completion	28 December 2021
Estimated completion	28 December 2021
Sites	65 locations across Martinique, France, Reunion, Mayotte

Drugs / interventions tested

Performing routine care (clinical and paraclinical tests)
Examinations for the research:

Conditions studied

Acute Myocarditis — all drugs for Acute Myocarditis →

Sponsor

University Hospital, Toulouse

Who can join

Eligibility, any sex, with Acute Myocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To date, the effects of SARS-Cov-2 (Covid-19) on the myocardium and the role it plays in the evolution towards an acute myocarditis are badly understood. The current pandemic of this emerging virus is an opportunity to assess the proportion of acute myocarditis attributable to SARS-Cov-2(Covid-19) and to assess the clinical, biological and imaging presentations, by means of a national prospective multicentre hospital registry of cases of acute myocarditis.

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
Raman B, Bluemke DA, Lüscher TF, Neubauer S. · · 2022 · cited 444× · PMID 35176758 · DOI 10.1093/eurheartj/ehac031
Cardiac involvement in the long-term implications of COVID-19.
Satterfield BA, Bhatt DL, Gersh BJ. · · 2022 · cited 101× · PMID 34686843 · DOI 10.1038/s41569-021-00631-3
What we (don't) know about myocardial injury after COVID-19.
Friedrich MG, Cooper LT. · · 2021 · cited 32× · PMID 33713116 · DOI 10.1093/eurheartj/ehab145
Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study.
Gorecka M, McCann GP, Berry C, Ferreira VM, et al · · 2021 · cited 14× · PMID 34112195 · DOI 10.1186/s12968-021-00752-1
Imaging in the COVID-19 era: Lessons learned during a pandemic.
Sideris GA, Nikolakea M, Karanikola AE, Konstantinopoulou S, et al · · 2021 · cited 7× · PMID 34249239 · DOI 10.4329/wjr.v13.i6.192
Coronavirus disease vaccination in heart failure: No time to waste.
Roncalli J, Roubille F, Lamblin N, Girerd N, et al · · 2021 · cited 6× · PMID 34099378 · DOI 10.1016/j.acvd.2021.04.004
Acute myocarditis according to age: Presentation, management and early outcomes.
Karsenty C, Vignaud P, Brusq C, Moceri P, et al · · 2025 · cited 1× · PMID 40405538 · DOI 10.1002/ehf2.15304
Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management.
Pascual-Figal DA, García-Serna AM, Esteban-Gil A, Fuster JJ, et al · · 2026 · PMID 41711201 · DOI 10.1093/eschf/xvag022

Verify or expand the search:

Other recruiting trials for Acute Myocarditis

Currently open trials in the same condition.

NCT05855746 — Colchicine Versus Placebo in Acute Myocarditis Patients · Phase 3 · recruiting
NCT05974462 — MYTHS-MR Trial (MYocarditis THerapy With Steroids in Patients With Mildly Reduced Ejection Fraction) · Phase 3 · recruiting

Other University Hospital, Toulouse trials

Trials by the same sponsor.

NCT07497750 — Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver D · NA · not yet recruiting
NCT07507240 — The Benefits of a Care Pathway Combining Remote Monitoring and Support From a Nurse After a Change in Anti-epileptic Tre · NA · not yet recruiting
NCT07524088 — Contamination of Young Children Hair During Acute Cannabis Intoxication · NA · not yet recruiting
NCT07470580 — Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension · NA · not yet recruiting
NCT07423988 — Evaluation of Changes in Sleep Efficiency Among PIC DU MIDI Staff Between Nights Spent at Home and Nights Spent in the W · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04375748 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Toulouse
Last refreshed: 24 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04375748.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing